Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06221124 · ClinicalTrials.gov registry record · NA

Ring-type Pulse Oximeter for Evaluation for Sleep Assessment Study

A NA study, sponsored by Belun Technology Company Limited.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT06221124 is a NA study that has completed, run by Belun Technology Company Limited. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06221124, a NA study, has completed, sponsored by Belun Technology Company Limited.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

Recently, various electronic lifestyle activity monitoring devices (ELAM) are increasingly commercially available. However, the quality and reliability of the data from ELAM are unclear, compared with polysomnography (PSG), which is the gold-standard sleep assessment method. Thus, combining ELAM with PSG will validate ELAM and improve its clinical and research utilization. The investigators propose to conduct this study to validate ELAM device for sleep assessment. The investigators will compare Belun Ring data collection and overnight in-lab PSG measures of Sleep-Disordered Breathing (SDB) and sleep architecture in adults with obstructive sleep apnea (OSA) symptoms. The investigators propose to recruit a total of 40 participants with symptoms of OSA. The overall accuracy, sensitivity and specificity of Belun Ring to assess SDB and sleep architecture will be validated by using PSG analysis as a gold standard.

Interventions

  • DEVICE Belun Ring Pulse Oximeter

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-07-15
Est. Completion 2023-06-12
Phase NA

Sponsor

Belun Technology Company Limited

6 total trials

What the Registry Record Tells You About NCT06221124

The ClinicalTrials.gov registry entry for NCT06221124 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Belun Technology Company Limited, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Belun Ring Pulse Oximeter is the first listed.

NCT06221124 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06221124 about?

NCT06221124 is a clinical study titled "Ring-type Pulse Oximeter for Evaluation for Sleep Assessment Study". Recently, various electronic lifestyle activity monitoring devices (ELAM) are increasingly commercially available. However, the quality and reliability of the data from ELAM are unclear, compared with polysomnography (PSG), which is the gold-standard sleep assessment method. Thus, combining ELAM wit...

What is the current status of trial NCT06221124?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2020-07-15. Estimated completion is 2023-06-12.

What interventions are being tested in trial NCT06221124?

The interventions under investigation include: Belun Ring Pulse Oximeter (DEVICE).

Who is sponsoring clinical trial NCT06221124?

This trial is sponsored by Belun Technology Company Limited, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.